Valuation: Biosenta Inc.

Market Cap 2.45M 1.75M 1.53M 1.44M 1.31M 168M 2.46M 17.2M 6.63M 85.37M 6.57M 6.43M 275M P/E 2024
-1.19x
P/E 2025 -1.59x
Enterprise Value 9.06M 6.46M 5.63M 5.31M 4.83M 619M 9.07M 63.55M 24.49M 315M 24.27M 23.73M 1.02B EV / Sales 2024
6,101x
EV / Sales 2025 8,809x
Free-Float
88.05%
Yield 2024 *
-
Yield 2025 -
1 day+85.71%
Current month+18.18%
1 month+18.18%
3 months+30.00%
6 months-18.75%
Current year-35.00%
1 month 0.04
Extreme 0.035
0.08
Current year 0.01
Extreme 0.01
0.12
1 year 0.01
Extreme 0.01
0.14
3 years 0.01
Extreme 0.01
0.89
5 years 0.01
Extreme 0.01
0.89
10 years 0
Extreme 0
2.5
Manager TitleAgeSince
Chief Executive Officer - 15/07/2019
Director TitleAgeSince
Chairman 90 15/07/2019
Director/Board Member - 04/10/2011
Chairman 65 16/02/2015
Date Insider Type Main position Quantity % Market Cap. Importance
02/05/26 Option

Chief Executive Officer

-210,000 0.6040%
02/05/26 Option

Director

-807,000 2.3210%
03/03/26 Option

Chief Executive Officer

625,000 1.8139%
Change 5-day change 1-year change 3-year change Capi.($)
+85.71%0.00%-53.57%-79.69% 1.75M
+0.80%-1.03%-14.93%-18.11% 42.28B
+0.78%+0.96%+5.69%+0.49% 22.65B
+2.14%-4.96%-30.23%-36.95% 10.26B
-0.14%+1.19%-3.07%-15.04% 4.66B
-1.82%0.00%-5.54%-57.03% 3.45B
-0.98%-2.27%+12.01%+20.16% 3.03B
+1.19%-0.11%-8.95%-5.49% 2.57B
-0.37%+1.05%+7.10%+37.10% 1.29B
-0.74%-3.71%+155.50%+881.04% 835M
Average +8.66%+7.69%+6.40%+72.65% 9.1B
Weighted average by Cap. +0.72%-1.59%-7.62%-6.26%

Financials

2024 2025
Net sales 1.38K 983.49 857.5 807.63 735.5 94.22K 1.38K 9.67K 3.73K 48K 3.69K 3.61K 155K 1.21K 863.67 753.04 709.24 645.9 82.74K 1.21K 8.49K 3.27K 42.15K 3.24K 3.17K 136K
Net income -2.23M -1.59M -1.39M -1.3M -1.19M -152M -2.23M -15.62M -6.02M -77.53M -5.97M -5.84M -250M -2.51M -1.79M -1.56M -1.47M -1.34M -171M -2.51M -17.58M -6.77M -87.22M -6.71M -6.56M -281M
Net Debt 5.54M 3.95M 3.45M 3.25M 2.96M 379M 5.55M 38.88M 14.99M 193M 14.85M 14.52M 623M 6.61M 4.71M 4.11M 3.87M 3.52M 451M 6.62M 46.35M 17.86M 230M 17.7M 17.31M 742M
Logo Biosenta Inc.
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It develops antimicrobial products that offer environmentally friendly solutions to a global market. Its flagship product, Tri-Filler, represents an antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. Tri-filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-filler can be embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, carpet rubber backing and synthetic tufts containing plastic, resin, textiles and others. Its true disinfectant is recognized by Health Canada for use in the fight against COVID-19.
Employees
-
Date Price Change Volume
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!